がん登録ソフトウェアの世界市場：現状分析と予測（2022年～2028年）

世界のがん登録ソフトウェアの市場規模は、予測期間中（2022年～2028年）にCAGRで約10.5%の成長が予測されています。市場成長の主な促進要因の1つは、世界中でのがんの発生率の増加です。

当レポートでは、世界のがん登録ソフトウェア市場について調査分析し、市場力学、動向と機会、企業プロファイルなどの情報を提供しています。

目次

第1章 市場のイントロダクション

第2章 調査手法・前提条件

第3章 市場の要約

第4章 エグゼクティブサマリー

第5章 ん登録ソフトウェア市場に対するCOVID-19がの影響

第6章 がん登録ソフトウェア市場の収益（2020年～2028年）

第7章 市場の考察：タイプ別

• スタンドアロン
• 統合

第8章 市場の考察：展開別

• クラウド
• オンプレミス

第9章 市場の考察：機能性別

• がんの報告
• 患者のケア
• 医学研究
• その他

第10章 市場の考察：エンドユーザー別

• 政府
• 民間企業
• 病院
• バイオテクノロジー製薬企業
• その他

第11章 市場の考察：地域別

• 北米
  • 米国
  • カナダ
  • その他の北米
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他の欧州
• アジア太平洋
  • 中国
  • 日本
  • インド
  • その他のアジア太平洋
• その他の地域

第12章 がん登録ソフトウェアの市場力学

• 市場促進要因
• 市場の課題
• 影響の分析

第13章 がん登録ソフトウェア市場の機会

第14章 がん登録ソフトウェア市場の動向

第15章 デマンドサイドとサプライサイドの分析

• デマンドサイド分析
• サプライサイド分析

第16章 バリューチェーン分析

第17章 競合シナリオ

• 競合情勢
  • ポーターのファイブフォース分析

第18章 企業プロファイル

• Rocky Mountain Cancer Centers
• MCKESSON CORPORATION
• Netdox Health Pvt. Ltd.
• Elekta
• IBM
• C-Net Solutions
• Ordinal Data, Inc
• Omega Healthcare
• Energy & Resource Solutions
• Conduent, Inc.

第19章 免責事項

The Cancer Registry Software Market is expected to witness a CAGR of around 10.5% during the forecast period i.e., 2022-2028. Cancer registry software is a database or information system that helps collect information about cancer patients. One of the key factors driving the growth of the global cancer registry software market is the increasing incidence of cancer across the globe. For instance, according to the California Institute for Regenerative Medicine (CIRM) prostate cancer is the second leading cause of cancer death among men in the U.S., with a 60% occurrence rate in men over the age of 65. Approximately 61,860 patients are expected to die from prostate cancer in California in the year 2021. Cancer registry software helps track and monitor the health status of patients suffering from cancer. Data collected using cancer registry software helps researchers and doctors develop therapies to treat cancer. Therefore, the global cancer registry software market is expected to grow in the coming years.

In addition, the rising geriatric population is also boosting the growth of the cancer registry software market during the forecast period. Data collected by cancer registry software helps stop the spread of cancer around the world. The software also helps governments track patients in specific locations and regions. As a result, this factor is supporting the growth of the global cancer registry software market.

Based on type, the market is segmented into standalone and integration. The standalone segment is expected to grow significantly during the forecast period. Standalone cancer registry software integrated with the latest and most advanced features. It is also easy to use and operate. Standalone cancer registry software also helps reduce overhead. Therefore, all these factors are driving the growth of the segment.

On the basis of deployment, the market is bifurcated into on-premises and cloud. The on-premise segment dominated the cancer registry software market in 2020. On-premise cancer registry software is primarily used by research institutions that conduct cancer research. On-premise cancer registry software offers advanced features for easy data storage such as security and easy accessibility. On-premise cancer registry software is less risky compared to other types of models. As such, on-premise cancer registry software is widely used in hospitals and research centers.

Based on the functionality the market is segmented into cancer reporting, patient care, medical research, and others. The patient care segment is expected to grow significantly during the forecast period. Patient care management is a program that includes a variety of healthcare services that help patients monitor their condition, from primary care such as scheduling appointments to short-term case management and chronic illness management. The growing number of cancer patients is attributed to the segment growth during the forecast period.

Based on end-user, the market is segmented into government, private players, hospitals, biotech pharma, and others. The government sector dominated the cancer registry software market in 2021. Governments in established and emerging countries have adopted cancer registry software on a large scale. This software helps track and monitor cancer patients in their respective regions. Added to this is government investment in implementing cancer registry software in hospitals. These factors are expected to boost of the global cancer registry software market during the forecast period.

For a better understanding of the market adoption of the cancer registry software industry, the market is analyzed based on its worldwide presence in the countries such as North America (The U.S., Canada, Rest of North America), Europe (Germany, The U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. The North American region is leading the cancer registry software market and is expected to maintain this during the forecast period. The presence of key market players is expected to propel the cancer registry software market in the region. Furthermore, government-funded efforts to support the development of cancer registries, and heavy investment in healthcare IT, are expected to significantly influence the market during the anticipation period. Moreover, the growing number of cancer patients in the region is also expected to drive the market during the analysis time period.

Some of the major players operating in the market include: Rocky Mountain Cancer Centers, MCKESSON CORPORATION, Netdox Health Pvt. Ltd, Elekta, IBM, C-Net Solutions, Ordinal Data Inc., Omega Healthcare, Energy & Resource Solutions, and Conduent, Inc.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

• 1.1. Market Definitions
• 1.2. Main Objective
• 1.3. Stakeholders
• 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

• 2.1. Research Process of the Cancer Registry Software Market
• 2.2. Research Methodology of the Cancer Registry Software Market
• 2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE CANCER REGISTRY SOFTWARE MARKET

6 CANCER REGISTRY SOFTWARE MARKET REVENUE, 2020-2028F

7 MARKET INSIGHTS BY TYPE

• 7.1. Standalone
• 7.2. Integration

8 MARKET INSIGHTS BY DEPLOYMENT

• 8.1. Cloud
• 8.2. On-Premises

9 MARKET INSIGHTS BY FUNCTIONALITY

• 9.1. Cancer Reporting
• 9.2. Patient Care
• 9.3. Medical Research
• 9.4. Others

10 MARKET INSIGHTS BY END-USER

• 10.1. Government
• 10.2. Private Players
• 10.3. Hospitals
• 10.4. Biotech Pharma
• 10.5. Others

11 MARKET INSIGHTS BY REGION

• 11.1. North America
  • 11.1.1. U.S.
  • 11.1.2. Canada
  • 11.1.3. Rest of North America
• 11.2. Europe
  • 11.2.1. Germany
  • 11.2.2. The U.K.
  • 11.2.3. France
  • 11.2.4. Italy
  • 11.2.5. Spain
  • 11.2.6. Rest of Europe
• 11.3. Asia-Pacific
  • 11.3.1. China
  • 11.3.2. Japan
  • 11.3.3. India
  • 11.3.4. Rest of Asia-Pacific
• 11.4. Rest of World

12 CANCER REGISTRY SOFTWARE MARKET DYNAMICS

• 12.1. Market Drivers
• 12.2. Market Challenges
• 12.3. Impact Analysis

13 CANCER REGISTRY SOFTWARE MARKET OPPORTUNITIES

14 CANCER REGISTRY SOFTWARE MARKET TRENDS

15 DEMAND AND SUPPLY-SIDE ANALYSIS

• 15.1. Demand Side Analysis
• 15.2. Supply Side Analysis

16 VALUE CHAIN ANALYSIS

17 COMPETITIVE SCENARIO

• 17.1. Competitive Landscape
  • 17.1.1. Porters Five Forces Analysis

18 COMPANY PROFILED

• 18.1. Rocky Mountain Cancer Centers
• 18.2. MCKESSON CORPORATION
• 18.3. Netdox Health Pvt. Ltd.
• 18.4. Elekta
• 18.5. IBM
• 18.6. C-Net Solutions
• 18.7. Ordinal Data, Inc
• 18.8. Omega Healthcare
• 18.9. Energy & Resource Solutions
• 18.10. Conduent, Inc.

19 DISCLAIMER